Brief: Checkpoint Therapeutics Announces $10 Mln Registered Direct Offering Priced At-The-Market Under NASDAQ Rules
23/05/2023 14:26
May 23 (Reuters) - Checkpoint Therapeutics Inc CKPT.O :
* CHECKPOINT THERAPEUTICS ANNOUNCES $10 MILLION REGISTERED
DIRECT
OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
Source text for Eikon: ID:nGNX8RWdv3
Further company coverage: CKPT.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Fortress Biotech
See all newsFortress Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Fortress Biotech Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Fortress Biotech And Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
Fortress Biotech Q1 net income jumps on PRV sale
Brief: Journey Medical Corporation Secures Contract With Third Major Gpo For Emrosi